Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 1Other hematologic neoplasm 1Other 1

Conditions

Neutropenia 1Mucositis 1Infections 1Hyperphagia 1Colitis 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × fish oil triglycerides × Other × Clear all
NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed
14 enrolled
Other

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡